Literature DB >> 3874206

Specific modification of the functional arginine residue in soybean trypsin inhibitor (Kunitz) by peptidylarginine deiminase.

H Takahara, H Okamoto, K Sugawara.   

Abstract

In order to elucidate the specificity of rabbit muscle peptidylarginine deiminase, which catalyzes the conversion of arginyl to citrullyl residues (Takahara, H., Oikawa, Y., and Sugawara, K. (1983) J. Biochem. (Tokyo) 94, 1945-1953), we examined the action of this enzyme on a variety of trypsin inhibitors by assay of residual trypsin-inhibiting activity. The enzyme rapidly abolished the activity of soybean trypsin inhibitor (Kunitz) (STI) in a process that was pseudo-first order with the rate dependent on enzyme concentration (second order rate constant = 5.0 X 10(4) M-1 S-1), whereas no detectable changes in activity were noted for other inhibitors tested. Inactivation of STI was due to the conversion of 1 arginine to a citrulline residue and was accompanied with a 0.2 unit decrease of the isoelectric point. There was no alteration of the molecular size and overall conformation of STI. Furthermore, analysis of modified STI indicated that arginine 63, known as the reactive site of STI, is the residue modified by peptidylarginine deiminase. Thus, peptidylarginine deiminase selectively catalyzes the deimination of the functional arginine residue of STI.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874206

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I.

Authors:  Marina Guerrin; Akihito Ishigami; Marie-Claire Méchin; Rachida Nachat; Séverine Valmary; Mireille Sebbag; Michel Simon; Tatsuo Senshu; Guy Serre
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

2.  D-glyceraldehyde-3-phosphate dehydrogenase. Properties of the enzyme modified at arginine residues.

Authors:  N K Nagradova; E V Schmalhausen; P A Levashov; R A Asryants; V I Muronetz
Journal:  Appl Biochem Biotechnol       Date:  1996 Oct-Nov       Impact factor: 2.926

3.  Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.

Authors:  Kyouhei Arita; Toshiyuki Shimizu; Hiroshi Hashimoto; Yuji Hidaka; Michiyuki Yamada; Mamoru Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  The anticoagulant activation of antithrombin by heparin.

Authors:  L Jin; J P Abrahams; R Skinner; M Petitou; R N Pike; R W Carrell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  PADI4 and tumourigenesis.

Authors:  Xiaotian Chang; Kehua Fang
Journal:  Cancer Cell Int       Date:  2010-03-12       Impact factor: 5.722

Review 6.  Deimination, Intermediate Filaments and Associated Proteins.

Authors:  Julie Briot; Michel Simon; Marie-Claire Méchin
Journal:  Int J Mol Sci       Date:  2020-11-19       Impact factor: 5.923

7.  Investigating citrullinated proteins in tumour cell lines.

Authors:  Zhongmin Jiang; Yazhou Cui; Lin Wang; Yan Zhao; Suhua Yan; Xiaotian Chang
Journal:  World J Surg Oncol       Date:  2013-10-07       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.